CSE CALI  |  Last $0.12  |  Change 0.00 OTC FNNZF  |  Last $0.10  |  Change 0.00

CTI is one of the first companies to operate a legal solvent extraction facility for cannabis in California. The company produces THC concentrates through BHO extraction to create custom formulations at its state-of-the-art, licensed lab which includes the latest technologies. The company is working to maximize commercialization of its products from the facility, which can process an estimated 6,000 pounds of biomass per month, translating to approximately 3.7 million grams of raw cannabis oil per year.  CTI is permitted to operate this facility at Coachella on an interim basis.

The Coachella Interim Extraction Facility includes extraction, manufacturing and distribution, and FinCanna is entitled to 50% of the profits from this venture, which  consists of:

  • Manufacturing and Distribution of CTI’s owned branded products.  “Coachella™ Premium brand products is the first and currently only CTI brand. This brand includes cannabis concentrates and vape cartridges.  Distributed at 10 dispensaries when announced on June 4, 2018;
  • Contract Manufacturing and Distribution for other brands. Includes an agreement with Phoenix Tears LLC to be exclusive manufacturer and distributer of official Phoenix Tears THC based products in California;
  • Extraction-as-a-Service for other manufacturers;
  • Distribution-as-a-service that provides state-licensed cannabis distribution, transportation, and sales efforts for select brands in California.

Please see press release dated January 15, 2018 for additional details on CTI’s Extraction Facility.

Distribution Partners: 

 

Subscribe for Updates